PRAME and acute leukemia: We demonstrated that fluorescent anti-PRAME antibodies allow for immunotyping bone marrow cells of patients with acute leukemia for the presence of the PRAME protein [31], which significantly affects the course of the disease and further prognosis [36,37,38,39,40,41,42].